Vigorous Stocks Need to Consider: PPG Industries, Inc. (NYSE:PPG), Cemtrex, Inc. (NASDAQ:CETX)

Shares of PPG Industries, Inc. (NYSE:PPG) [Trend Analysis] swings enthusiastically in regular trading session, it a decrease of -0.18% to close at $95.68. PPG (PPG) declared on Friday that a definitive contract to sell the assets of its Mexico-based Plaka plasterboard and cement-board business to Knauf International GmbH. The financial terms were not disclosed.The transaction is expected to close in the first half of 2017.

The business employs about 200 people and operates a manufacturing facility in Querétaro, Mexico.PPG acquired the Plaka business in 2014 as part of its acquisition of Comex, S.A. de C.V. Plaka, with approximate sales of $30 million in 2015, manufactures plasterboard, cement board and drywall primarily for the Mexican construction market. Moving forward to saw long-term intention, the experts calculate Return on Investment of 15.80%. The stock is going forward its fifty-two week low with 9.98% and lagging behind from its 52-week high price with -17.25%. PPG last month stock price volatility remained 1.54%.

Cemtrex, Inc. (NASDAQ:CETX) [Trend Analysis] retains strong position in active trade, as shares scoring 0.69% to $6.46 in a active trade session, while looking at the shares volume, around 74232 shares have changed hands in this session. Cemtrex, Inc. (CETX) declared that it is launching tomorrow its previously reported $15.0 million subscription rights offering. The offering will allow Cemtrex’s stockholders of record to purchase up to 1,500,000 units, each consisting of one share of series 1 preferred stock, paying cumulative dividends at the rate of 10 percent of the purchase price per year, and two five-year series 1 warrants, upon the exercise of subscription rights at the purchase price of $10.00 per unit.

The exercise price of the series 1 warrants has been set at $6.31 per share, representing 115 percent of the five-day volume weighted average price per share of common stock prior to and including the record date of the rights offering. The firm has institutional ownership of 3.40%, while insider ownership included 70.91%. CETX attains analyst recommendation of 2.00 with week’s performance of 27.38%.


About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Reply

Your email address will not be published. Required fields are marked *